Tech Company Financing Transactions
RedPath Integrated Pathology Funding Round
CID Capital and NewSpring Capital invested in a $1.6 million capital raise for RedPath Integrated Pathology. The funding round closed on 6/30/2011.
Transaction Overview
Company Name
Announced On
6/30/2011
Transaction Type
Venture Equity
Amount
$1,600,000
Round
Undisclosed
Investors
CID Capital (Peter Kleinhenz)
NewSpring Capital (Brian Murphy)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Morris Corporate Center 1 300 Interpace Pkwy.
Pittsburgh, PA 07054
USA
Pittsburgh, PA 07054
USA
Phone
Website
Email Address
Overview
RedPath Integrated Pathology, Inc. is a pathology services company that integrates traditional pathology practice with molecular genetic analysis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jack Stover
Chief Financial Officer
Nat Krishnamurti
Chief Scientific Officer
Sydney Finkelstein
VP - Bus. Development
Sara Jackson
VP - Operations
Glenn Gershon
Browse more venture capital transactions:
Prev: 6/30/2011: InhaleDigital venture capital transaction
Next: 6/30/2011: AxioMed venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs